Involvement of cannabinoid CB1- and CB2-receptors in the modulation of exocrine pancreatic secretion

Pharmacological Research

Volumn 59, Issue 3, 2009, Pages 207-214

  Linari, G ^a   Agostini, S ^a   Amadoro, G ^b   Ciotti, M T ^b   Florenzano, F ^c   Improta, G ^a   Petrella, C ^a   Severini, C ^b   Broccardo, M ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b CNR   (Italy)

^c IRCCS FONDAZIONE SANTA LUCIA   (Italy)

Author keywords

Cannabinoid receptors; Exocrine pancreas; Guinea pig and rat; WIN55,212

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; CANNABINOID 1 RECEPTOR; CANNABINOID 1 RECEPTOR ANTAGONIST; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR ANTAGONIST; CARBACHOL; CERULETIDE; POTASSIUM CHLORIDE;

ACETYLCHOLINE RELEASE; ACINAR CELL; AMYLASE RELEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ASSAY; GUINEA PIG; IMMUNOCHEMISTRY; IMMUNOFLUORESCENCE; MALE; NONHUMAN; PANCREAS ACINUS; PANCREAS SECRETION; PANCREATITIS; PRESYNAPTIC NERVE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; RECEPTOR DOWN REGULATION; REGULATORY MECHANISM; WESTERN BLOTTING;

AMYLASES; ANIMALS; BENZOXAZINES; BLOTTING, WESTERN; GUINEA PIGS; MALE; MORPHOLINES; NAPHTHALENES; PANCREAS, EXOCRINE; PANCREATITIS; RATS; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2;

EID: 59349103952     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2008.11.002     Document Type: Article

References (54)

1. Grotenhermen F. Cannabinoids. Curr Drug Targets CNS Neurol Disord 4 5 (2005) 507-530
2. Howlett A.C., Breivogel C.S., Childers S.R., Deadwyler S.A., Hampson R.E., and Porrino L.J. Cannabinoid physiology and pharmacology: 30 years of progress. Neuropharmacology 47 Suppl 1 (2004) 345-358
3. Pertwee R.G. Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol Ther 74 (1997) 129-180 (B)
4. Freund T.F., Katona I., and Piomelli D. Role of endogenous cannabinoids in synaptic signaling. Physiol Rev 83 3 (2003) 1017-1066 [Review]
5. Casu M.A., Porcella A., Ruiu S., et al. Differential distribution of functional cannabinoid CB1 receptors in the mouse gastroenteric tract. Eur J Pharmacol 459 (2003) 97-105
6. Coutts A.A., Irving A.J., Mackie K., Pertee R.G., and Anavi-Goffer S. Localisation of cannabinoid (CB1) receptor immunoreactivity in the guinea pig and rat myenteric plexus. J Comp Neurol 448 (2002) 410-422
7. Croci T., Manara L., Aureggi G., Guagnini F., Rinaldi-Carmona M., Maffrand J.P., Le Fur G., Mukenge S., and Ferla G. In vitro functional evidence of neuronal cannabinoid CB1 receptors in human ileum. Br J Pharmacol 125 (1998) 1393-1395
8. Samson H.T., Small-Houard A., Shimada L.M., Koblan-Huberson M., Stokes A.J., and Tumez H. Differential roles of CB1 and CB2 cannabinoid receptors in mast cells. J Immunol 170 (2003) 4953-4962
9. Van Sickle M.D., Duncan M., Kingsley P.J., et al. Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science 310 (2005) 329-332
10. Izzo A.A., and Camilleri M. Emerging role of cannabinoids in gastrointestinal and liver diseases: basic and clinical aspects. Gut 57 8 (2008) 1140-1155
11. Duncan M., Davison J.S., and Sharkey K.A. Endocannabinoids and their receptors in the enteric nervous system. Aliment Pharmacol Ther 22 (2005) 667-683
12. Basvarajappa B.S. Critical enzymes in endocannabinoid metabolism. Protein Pept Lett 14 (2007) 237-246
13. Coutts A.A., and Izzo A.A. The gastrointestinal pharmacology of endocannabinoids. An update. Curr Opin Pharmacol 4 (2004) 572-579
14. Massa F., and Monroy K. Endocannabinoids and the gastrointestinal tract. J Endocrinol Invest 29 3 (2006) 47-57
15. Coruzzi G., Adami M., Guaita E., et al. Effects of cannabinoid receptor agonists on rat gastric acid secretion: discrepancy between in vitro and in vivo data. Dig Dis Sci 5 (2006) 310-317
16. Izzo A.A., Mascolo N., Papasso R., Germanò M.P., De Pasquale R., and Papasso F. Inhibitory effect of cannabinoid agonists on gastric emptying in the rat. Naunyn Schmiedebergs Arc Pharmacol 360 (1999) 221-223
17. Pinto L., Izzo A.A., Cascio M.G., et al. Endocannabinoids as physiological regulators of colonic propulsion in mice. Gastroenterology 123 (2002) 227-234
18. Heinemann A., Shahbazian A., and Holzer P. Cannabinoid inhibition of guinea pig intestinal peristalsis via inhibition of excitatory and activation of inhibitory neural pathways. Neuropharmacology 38 (1999) 1289-1297
19. Yuece B., Sibaev A., Broedl U.C., et al. Cannabinoid type 1 receptor modulates intestinal propulsion by an attenuation of intestinal motor responses within the myenteric part of the peristaltic reflex. Neurogastroenterol Motil 19 (2007) 744-753
20. Muccioli G.G., and Lambert D.M. Current knowledge on the antagonists and inverse agonist of cannabinoid receptors. Curr Med Chem 12 (2005) 1391-1394
21. Jagerovic N., Fernandez-Fernandez C., and Goya P. CB1 cannabinoid antagonists: structure-activity relationships and potential therapeutic applications. Curr Top Med Chem 8 (2008) 205-230
22. Mulè F., Amato A., Baldassano S., and Serio R. Involvement of CB1 and CB2 receptors in the modulation of cholinergic neurotransmission in mouse gastric preparations. Pharmacol Res 56 3 (2007) 185-192
23. Chaudhry A., Thompson R.H., Rubin R.P., and Laychock S.G. Relationship between delta-9-tetrahydrocannabinol-induced arachidonic acid release and secretagogue-evoked phosphoinositide breakdown and Ca2+ mobilization of exocrine pancreas. Mol Pharmacol 34 4 (1988) 543-548
24. Busch L., Sterin-Borda L., and Borda E. Expression and biological effects pf CB1 cannabinoid receptor in rat parotid gland. Biochem Pharmacol 68 9 (2004) 1767-1774
25. Michalski C.W., Laukert T., Sauliunaite D., et al. Cannabinoids ameliorate pain and reduce disease pathology in cerulein-induced acute pancreatitis. Gastroenterology 132 5 (2007) 1968-1978
26. Dembiński A., Warzecha Z., Ceranowicz P., et al. Cannabinoids in acute gastric damage and pancreatitis. J Physiol Pharmacol 57 Suppl (2006) 5137-5154
27. Matsuda K., Mikami Y., Takeda K., et al. The cannabinoid 1 receptor antagonist, AM251, prolongs the survival of rats with severe acute pancreatitis. Tohoku J Exp Med 207 October (2) (2005) 99-107
28. Wargo K.A., Geveden B.N., and McConnell V.J. Cannabinoid-induced pancreatitis: a case series. JOP 8 5 (2007) 579-583
29. Scheele A.G., and Palade G.E. Parallel discharge of exocrine enzyme activities. J Biol Chem 250 (1975) 660-675
30. Peikin S.R., Rotman A.J., Baztri S., and Gardner J. Kinetics of amylase release by dispersed acini prepared from guinea pig pancreas. Am J Physiol 235 6 (1978) E743-E749
31. Ceska M., Brown B., and Birath K. Ranges of alpha-amylase activities in human serum and urine and correlations with some other alpha-amylase methods. Clin Chim Acta 26 3 (1969) 445-453
32. Clemons A.P., Holstein D.M., Galli A., and Saunders C. Cerulein-induced acute pancreatitis in the rat is significantly ameliorated by treatment with MEK1/2 inhibitors U0126 and PD98059. Pancreas 25 (2002) 251-259
33. Eggan S.M., and Lewis D.A. Immunocytochemical distribution of the cannabinoid CB1 receptor in the primate neocortex: a regional and laminar analysis. Cereb Cortex 17 1 (2007) 175-191
34. Bermudez-Silva F.J., Suarez J., Baixeras E., et al. Presence of functional cannabinoid receptors in human endocrine pancreas. Diabetologia 51 (2008) 476-487
35. Ashton J.C., Zheng Y., Lin P., et al. Immunohistochemical characterization and localization of cannabinoid CB1 receptor protein in the rat vestibular nucleus complex and the effects of unilateral vestibular differentiation. Brain Res 1021 2 (2004) 264-271
36. Roche M., Diamond M., Kelly J.P., and Finn D.P. In vivo modulation of LPS-induced alterations in brain and peripheral cytokines and HPA axis activity by cannabinoids. J Neuroimmunol 182 1-2 (2006) 57-67
37. Gong J.P., Onaivi E.S., Ishiguro H., et al. Cannabinoid CB2 receptor: immunohistochemical localization in rat brain. Brain Res 1071 1 (2006) 10-23
38. Velenzela J.E., Weiner K., and Saad C. Cholinergic stimulation of human pancreatic secretion. Dig Dis Sci 31 (1986) 615-619
39. Louie D.S., Chen H.T., and Owyang C. Inhibition of exocrine pancreatic secretion by opiates is mediated by suppression pf cholinergic transmission: characterization of receptor subtypes. J Pharmacol Exp Ther 246 1 (1998) 132-136
40. Linari G., Agostini S., Broccardo M., Petrella C., and Improta G. Regulation of pancreatic secretion in vitro by nociceptin/orphanin FQ and opioid receptors: a comparative study. Pharmacol Res 54 5 (2006) 356-360
41. Herzig K.H., Brunke G., SchÖn I., Shäffer M., and FÖlsch U.R. Mechanism of galanin's inhibitory action on pancreatic enzyme secretion: modulation of cholinergic transmission-studies in vivo and in vitro. Gut 34 11 (1993) 1616-1621
42. Herzig K.H., Louie D.S., Tatemoto K., and Chung O.Y. Pancreastatin inhibits pancreatic enzyme secretion by presynaptic modulation of acetylcholine release. Am J Physiol 262 1 (1992) G113-G117
43. Kirchgessner A.L., and Gershon M.D. Presynaptic inhibition by serotonin of nerve-mediated secretion of pancreatic amylase. Am J Physiol 268 2 (1995) G339-G345
44. Hinds N.M., Ullrich K., and Smid S.D. Cannabinoid 1 (CB1) receptors coupled to cholinergic motoneurones inhibit neurogenic circular muscle contractility in the human colon. Br J Pharmacol 148 (2006) 191-199
45. Rinaldi-Carmona M., Barth F., Heaulme M., Alonso R., Shire D., Congy C., Sobrie P., Breliere J.C., and Le Fur G. Biochemical and pharmacological characterisation of SR141716A, the first potent and selective brain cannabinoid receptor antagonist. Life Sci 56 (1995) 1941-1947
46. Leach S.D., Modlin I.M., Scheele G.A., and Gorelick F.S. Intracellular activation of digestive zymogens in rat pancreatic acini stimulation by high doses of cholecystokinin. J Clin Invest 87 (1991) 362-366
47. Hou W., Arita Y., and Morisset J. Endogenous arachidonic acid release and pancreatic amylase secretion. Pancreas 14 3 (1997) 301-308
48. Broccardo M., Linari G., Agostini S., Amadoro G., Carpino F., Ciotti M.T., Petrella C., Petrozza V., Severini C., and Improta G. Expression of NK-1 and NK-3 tachykinin receptors in pancreatic acinar cells after acute experimental pancreatitis in rats. Am J Physiol Gastrointest Liver Physiol 291 3 (2006) G518-G524
49. Bhatia M., Saluja A.K., Singh V.P., Frossard J.L., Lee H.S., Bhagat L., Gerard C., and Steer M.L. Complement factor C5a exerts an anti-inflammatory effect in acute pancreatitis and associated lung injury. Am J Physiol Gastrointest Liver Physiol 280 (2001) G974-G978
50. Grant P., and Gandhi P. A case of cannabis-induced pancreatitis. JOP 5 1 (2004) 41-43
51. Chaudhuri A., Kolodecik T.R., and Gorelick F.S. Effects of increased intracellular cAMP on carbachol-stimulated zymogen activation, secretion, and injury in the pancreatic acinar cell. Am J Physiol Gastrointest Liver Physiol 288 2 (2005) G235-G243
52. 2+, cAMP, and PKC in pancreatic acinar cells. Biochem Biophys Res Commun 334 (2005) 1241-1247
53. Van Acker G.J., Weiss E., Steer M.L., and Perides G. Cause-effect relationships between zymogen activation and other early events in secretagogue-induced acute pancreatitis. Am J Physiol Gastrointest Liver Physiol 292 6 (2007) G1738-G1746
54. Singh V.P., Bhagat L., Navina S., Sharif R., Dawra R.K., and Saluja A.K. Protease-activated receptor-2 protects against pancreatitis by stimulating exocrine secretion. Gut 56 7 (2007) 958-964